Xtant Medical Holdings, Inc.
XTNT · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 28.4% | 57.5% | 4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.2% | 60.8% | 55.4% | 58.8% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -6.7% | 5.6% | -9.4% | -4.5% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -14% | 0.7% | -14.6% | -8.8% |
| EPS Diluted | -0.12 | 0.005 | -0.09 | -0.057 |
| % Growth | -2,407.7% | 105.8% | -59.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |